Susan Vissers Lisa | Boston Scientific Corp. |
Michael F. Mahoney | Boston Scientific Corp. |
Daniel J. Brennan | Boston Scientific Corp. |
Ian T. Meredith | Boston Scientific Corp. |
Kenneth Stein, M.D. | Boston Scientific Corp. |
David Ryan Lewis | Morgan Stanley & Co. LLC |
Glenn John Novarro | RBC Capital Markets LLC |
Frederick Wise | Stifel, Nicolaus & Co., Inc. |
Lawrence Biegelsen | Wells Fargo Securities LLC |
Joanne Karen Wuensch | BMO Capital Markets (United States) |
Robert J. Marcus | JPMorgan Securities LLC |
Christopher Pasquale | Guggenheim Securities LLC |
Bruce M. Nudell | SunTrust Robinson Humphrey, Inc. |
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Q2 2018 earnings call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will be given at that time.